New roots for AstraZeneca

Jul 3, 2013 : Since taking over as chief executive last October, Pascal Soriot has been under pressure to turn round the fortunes of the Anglo-Swedish pharmaceutical group. He tells the FT's Andrew Jack about the restructuring and why the group has has decided to base its global headquarters in Cambridge.
1 - 12 COMPANIES & MANAGEMENT (30)